What’s New in Testing
2011 Testing Report
This report includes data submitted to CDC for testing events funded by five program announcements funding comprehensive HIV prevention services; expanded HIV testing services for disproportionately affected populations; HIV testing services for CBOs in Puerto Rico and U.S. Virgin Islands; HIV prevention interventions for CBOs; and HIV prevention interventions serving young men of color who have sex with men and young transgendered persons of color for CBOs.
Getting an HIV test is the only way to know if you have HIV. This section answers some of the most common questions related to HIV testing, including the types of tests available, where to get one, and what to expect when you go to get tested.
This document is a draft of CDC recommendations for laboratory-based HIV testing in the US. This draft information has not been formally disseminated by the Centers for Disease Control and Prevention, the Health Resources and Services Administration, or the U.S. Department of Health and Human Services. This draft information does not represent and should not be construed to represent any agency determination or policy. The draft report describes use of tests for some indications that do not reflect labeling approved by the U.S. Food and Drug Administration (FDA) at the time of publication.
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians screen adolescents and adults ages 15 to 65 years for HIV infection. Younger adolescents and older adults who are at increased risk should also be screened. This is a grade A recommendation. The USPSTF recommends that clinicians screen all pregnant women for HIV, including those who present in labor whose HIV status is unknown. This is a grade A recommendation.